The third meeting of Western alliance held in Guiyang

The third joint meeting of president and Secretary General of Western Pharmaceutical Association Alliance and 2015 Western pharmaceutical industry and commerce development meeting were held in Guiyang from September 23 to 26 The chairman and Secretary General of the Medical Association of Chongqing, Sichuan, Yunnan, Guizhou, Guangxi, Shaanxi, Gansu and other provinces and cities, members of the Western alliance, attended the meeting Huang Zhuyun, chief economist of Guizhou Provincial Department of Commerce, attended the meeting to congratulate and introduce the development of Guizhou pharmaceutical industry Guo Jianzhong, President of Guizhou pharmaceutical business association, delivered a welcome speech to the participants Wu Bin, executive vice president of China Pharmaceutical Business Association, and Wang Guihua, Secretary General of China traditional Chinese Medicine Association, respectively, were invited to give wonderful speeches for the meeting on the topics of "hot spots in the pharmaceutical circulation industry and path thinking of transformation and upgrading" and "some experiences in the current Chinese medicine industry" Yingjun, deputy general manager of reed Sinopharm exhibition, Wang Hong, Secretary General of North China nine provinces Pharmaceutical Industry Association, Yu Kaixiong, vice president of Hubei pharmaceutical industry association, Wang Chunlu, chairman of traditional Chinese medicine storage branch of China Warehousing Association, etc attended the meeting and delivered speeches Representatives of some medical enterprises and pharmaceutical parks in Guiyang, Sichuan, Chongqing and other provinces and cities attended the meeting Mr Zhang Yilong, chairman of Western pharmaceutical association, made a speech at the meeting on "strengthening the direction, improving the mechanism and making the alliance a public service platform for Western pharmaceutical industry" In his speech, he briefly summarized the work done in the past two years since the establishment of the Western alliance, mainly carried out the work of preparing the website and publications of the alliance; further expanded the participation of western provincial and municipal pharmaceutical industry associations; discussed and explored the development direction and path of the alliance He put forward several ideas on the next development path of Western alliance, one is to strengthen the direction of the alliance and accelerate the construction of the alliance; the other is to further improve the operation mechanism of the alliance; the third is to actively promote the integration and structural adjustment of western enterprise resources; the fourth is to explore the establishment of Western drug fair and Enterprise Forum; the fifth is to attract and rely on enterprises to participate in the construction of the alliance The representatives of the meeting held a heated discussion around Mr Zhang Yilong's speech and put forward many positive suggestions for further strengthening the alliance construction During the meeting, leaders of reed Pharma, Yuechi economic and Technological Development Zone Management Committee, Guizhou Gui'an investment promotion Co., Ltd., Guizhou Hanfang Pharmaceutical Co., Ltd., traditional Chinese medicine storage branch of China Warehousing Association, Chongqing Yaoyou Pharmaceutical Co., Ltd., Luzhou Tianshou pharmaceutical and other units respectively introduced their development or commercial promotion Delegates agreed that the meeting was a warm, pragmatic and successful one At the meeting, yaozhi.com introduced the plan to build the website of Western alliance; Sichuan Pharmaceutical Industry Association introduced the idea of adding Western alliance dynamics in the Journal of Sichuan medicine After heated and serious discussion, the meeting reached the following consensus: 1 To strengthen the direction of the alliance and accelerate the construction of the alliance; 2 To gradually establish and improve the operation mechanism of the alliance and establish the working contact system of the Secretary General; 3 To establish the website of the western pharmaceutical Alliance in yaozhi.com and open the column of "Western pharmaceutical alliance" in Sichuan Pharmaceutical 4 Give full play to the synergy of the alliance, actively promote the integration of enterprise resources and structural adjustment; 5 Mobilize and rely on the enthusiasm of enterprises to participate in and promote the construction of the alliance; 6 Strengthen the regional cooperation between the western pharmaceutical alliance and the nine provincial and municipal pharmaceutical alliance; 7 Build the communication platform between the western pharmaceutical enterprises, and explore the holding of the western pharmaceutical fair and Enterprise Forum focusing on border trade The meeting made the following three decisions: 1 The original "Western pharmaceutical industry association alliance" was renamed "Western Pharmaceutical Association Alliance" 2 The fourth meeting of Western pharmaceutical alliance was held in Yunnan in 2016; 3 Strengthen the links among provincial associations within the alliance, and realize the participation of western 12 provincial and municipal pharmaceutical associations and pharmaceutical enterprises in the alliance Link: Chongqing pharmaceutical industry overview Chongqing pharmaceutical industry association Chongqing used to be one of the important pharmaceutical industry bases in China After nearly 100 years of development, especially over 30 years of reform and opening up, it has formed a complete industrial system including pharmaceutical research and development, pharmaceutical industry, pharmaceutical commerce, medical devices, pharmaceutical machinery, pharmaceutical engineering and design, pharmaceutical education, etc At present, there are 124 pharmaceutical industry enterprises (excluding medical device enterprises), 580 drug distribution and wholesale enterprises and 14000 drug retail enterprises in the city The total output value of the city's pharmaceutical industry has reached 46 billion yuan, accounting for about 2.5% of the city's total industrial output value The total amount of medical commercial sales in the city has reached 50 billion yuan, accounting for about 3.5% of the total sales of commodities in the city The characteristics and advantages of Chongqing pharmaceutical industry (1) the innovation system of pharmaceutical industry has been basically formed and a number of high-level achievements have been developed First, an innovation platform system with the national level and provincial and ministerial level as the core has been formed There are a number of high-level medical research institutes and institutes in Chongqing, such as the Third Military Medical University, Chongqing Medical University, Chongqing College of higher medicine, Chongqing Institute of pharmaceutical industry and Chongqing Institute of traditional Chinese medicine At present, there are 12 national level technological innovation platforms, 45 provincial and ministerial level innovation platforms, and Chongqing pharmaceutical innovation technology industrialization alliance and international industry university research alliance have been established China US Biomedical Innovation Center Second, enterprises gradually become the main body of technological innovation The annual growth of R & D investment in Pharmaceutical Enterprises above designated size is about 15% The proportion of R & D investment in sales value is 2.3%, 0.2 percentage points higher than the national average level of pharmaceutical industry, and 1.2 percentage points higher than the city's industry Third, a number of independent innovation achievements have emerged Innovative drugs and medical devices with international advanced level, such as Rosiglitazone Sodium, oral Recombinant Helicobacter pylori vaccine, alprostadil microspheres freeze-dried emulsion, HIFU ultrasonic focusing knife, digestive tract intelligent capsule, have been on the market Seven new biotechnological drugs, such as anti HIV long-acting peptide drugs and recombinant human parathyroid hormone recombinant protein drugs, have a good prospect of industrialization （2） A number of key enterprises have been formed First, among the 115 pharmaceutical industry enterprises above Designated Size, there are 5.5 billion yuan level enterprises and 8 billion yuan level enterprises Six enterprises including Taiji group, southwest synthesis, Tiansheng pharmaceutical, Yaoyou pharmaceutical, Kerui pharmaceutical, Huabang pharmaceutical have entered the top 100 pharmaceutical industry in China Chongqing pharmaceutical Co., Ltd (Group) has an annual sales revenue of nearly 30 billion yuan, ranking sixth in the national pharmaceutical business, and has become the largest pharmaceutical business enterprise in Southwest China Second, after several GMP and GSP transformations, the hardware equipment and enterprise management level of enterprises have been improved significantly, and the vast majority of enterprises organize production and operation in accordance with international standards Third, a number of state-owned enterprises have shown a new trend of expansion and development through M & A and restructuring Huayi Group and Taiji group have accelerated their development through internal integration and M & A expansion, and Taiji Group has started to move towards the goal of "100 billion Taiji" Chongqing Yaoyou, Chongqing Medical Engineering Institute and Kailin pharmaceutical have integrated advanced corporate culture and management concept, strengthened R & D innovation and stepped into a sound and rapid development through the introduction of Fosun holding restructuring Southwest synthesis and Chongqing Daxin have shown great vitality by introducing the reorganization of Founder holding of Peking University, combining with relocation and transformation, expanding scale, transformation and upgrading Fourth, a number of private enterprises represented by Tiansheng, Huabang, Laimei, Fu'an, shenghuaxi, Zhien, hilan, Huasen, Zhifei, boten, kangkeri, etc have sprung up They give full play to the advantages of new system, flexible mechanism and quick response, and make great efforts in product research and development and marketing, showing a good growth and becoming a strong new force in Chongqing pharmaceutical industry Fifthly, with the public listing of a number of enterprises, it has strengthened the strength for the upgrading and transformation of enterprises At present, 10 enterprises have been successfully listed, including Southwest Pharmaceutical, Peking University Pharmaceutical (formerly southwest synthetic), TongJunGe, Taiji, Huabang, Laimei, Fu'an, Zhifei, boten, and a number of other enterprises are preparing to be listed （3） We have built a product structure with backbone products as the core At present, the city has 3500 drug approval numbers, and more than 2600 drugs are produced throughout the year There are more than 30 products with an annual sales volume of more than RMB 100 million, 6 products with an annual sales volume of more than RMB 500 million, and the market share of 15 products is the first in China; the market share of sulfadiazine and lovastatin APIs is the first in the world The city has 15 national famous trademarks and 30 municipal famous trademarks 25 products have become domestic industry brands More than 30 products of 5 enterprises in the city have passed the FDA certification, nearly 20 products have obtained the EU certification, and more than 20 characteristic APIs have passed the European and American international registration certification The characteristics and advantages of Chongqing pharmaceutical business Chongqing pharmaceutical business has been relatively developed, large-scale, high degree of modernization At present, there are 580 drug wholesale enterprises, 43 drug retail chain enterprises and nearly 14000 retail pharmacies in the city Since the 11th five year plan, the annual average growth rate of drug circulation in the city has remained above 20% At present, the total sales volume of pharmaceutical products has reached nearly 60 billion yuan (of which the retail sales account for about 35% of the total sales) Chongqing pharmaceutical distribution industry has the following characteristics and advantages: (1) high concentration of pharmaceutical wholesale business, dominated by state-owned enterprises The wholesale volume of Chongqing pharmaceutical (Group) Co., Ltd is more than 28 billion yuan, and that of Chongqing TongJunGe Co., Ltd is nearly 10 billion yuan, accounting for more than 70% of the city's sales Chongqing Jiuzhoutong, Guoyao holding (Chongqing), kantle (Chongqing), Chongqing Changsheng and other companies have annual sales revenue of more than 1 billion yuan, becoming the leading enterprise of Chongqing drug wholesale （2） Drug retail chain business started early with high chain degree Heping pharmacy and TongJunGe pharmacy are the earliest and largest drug chain brands in China At present, there are 14000 retail pharmacies and 13000 chain stores in the city, accounting for 92.0% of the total number of retail pharmacies, which is higher than the national average of about 30% Heping, TongJunGe, Wanhe, Xinhu and Liancheng (wanjiayan) have entered the top 100 chain pharmacies in China （3） Modern medicine logistics started early Heping pharmaceutical distribution center of Chongqing pharmaceutical (Group) Co., Ltd is one of the earliest large-scale modern logistics centers in China Chongqing pharmaceutical (Group), TongJunGe, Guoyao holding (Chongqing), Chongqing Changsheng, Chongqing Jiuzhoutong and other enterprises are also building or planning to build modern pharmaceutical logistics projects Chongqing medical equipment industry has obvious high-tech advantages Chongqing medical equipment industry started in the 1970s A group of private high-tech enterprises represented by "Haifu technology" and "Jinshan technology", relying on the scientific and technological strength of colleges and universities, set up a national level engineering center, jointly built national key disciplines and key laboratories, and set up a unique and innovative development path of medical equipment The intelligent capsule endoscope system of Jinshan Technology Co., Ltd and the high intensity focused ultrasound tumor treatment system of Haifu Technology Co., Ltd have become the leading high-tech products in the world Chongqing has also been approved by the Ministry of science and technology to establish the first medical device science and technology demonstration Industrial Park in China Medical devices are rapidly growing into a new industry in Chongqing At present, there are more than 400 medical device industry enterprises in Chongqing and more than 700 registered products The development momentum is in the ascendant At present, Chongqing municipal government has listed biomedicine and medical devices in the strategic emerging industries of Chongqing, and has set a grand development goal: by 2017, the scale of Chongqing will be